A controlled, randomized, open-label study to evaluate the effect of every-2-week darbepoetin alfa for anemia of cancer No significant financial relationships to disclose. This is an ASCO Meeting ...
Gauging the response of circulating epithelial tumor cells (CETC) and tumor stem cell subpopulations to therapy of early-stage cancer in the individual patient This is an ASCO Meeting Abstract from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results